<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJIM</journal-id><journal-title-group><journal-title>Open Journal of Internal Medicine</journal-title></journal-title-group><issn pub-type="epub">2162-5972</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojim.2013.32016</article-id><article-id pub-id-type="publisher-id">OJIM-32420</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Lamotrigine overdose cause skin rash and angioedema
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>ohammad</surname><given-names>Alkayem</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Hussein</surname><given-names>Assallum</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Department of Internal Medicine, Lincoln Medical and Mental Health Center, New York, USA</addr-line></aff><author-notes><corresp id="cor1">* E-mail:<email>mo54434@hotmail.com(OA)</email>;</corresp></author-notes><pub-date pub-type="epub"><day>28</day><month>05</month><year>2013</year></pub-date><volume>03</volume><issue>02</issue><fpage>63</fpage><lpage>65</lpage><history><date date-type="received"><day>9</day>	<month>April</month>	<year>2013</year></date><date date-type="rev-recd"><day>9</day>	<month>May</month>	<year>2013</year>	</date><date date-type="accepted"><day>16</day>	<month>May</month>	<year>2013</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
   <b>A </b><b>23 years old female </b><b>p</b><b>resent</b><b>ed</b><b> to Lincoln Medical and Mental Health center with skin rash and angioe</b><b>dema after she received 20 pills of lamotrigine 25 mg, </b><b>and </b><b>the patient used to take this medication before two tables a day for many months, after she received the appropriate management she improved. </b><b>A</b><b>fter re</b><b>viewing MEDLINE we found</b><b> a</b><b> few case</b><b>s</b><b> reported life threatening complications related to lamotrigine in</b><b>toxication and sudden increase the dose, so we should be aware about these complication</b><b>s</b><b> before prescrib</b><b>ing this medication.</b><b></b> 
 
</p></abstract><kwd-group><kwd>Lamotrigine; Over Dose; Angioedema</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. INTRODUCTION</title><p>To describe the physical manifestations of lamotrigine toxicity presenting as skin rash and angioedema.</p></sec><sec id="s2"><title>2. CASE REPORT</title><p>A 23 years old Hispanic female presented to Lincoln Medical and Mental Health Center with itchy rash affecting her face, body, and swelling of her eyelids and lower lip, after taking approximately 20 pills of lamotrigine in an apparent suicide attempt. She denies SOB, cough, fever, palpitation, headache or blurry vision. She has history of bipolar disorder and used to be on lamotrigine 25 mg bid for many months. No other significant medical history. No history of allergies. Patient uses Alcohol daily and Marijuana sometimes. Physical exam show mild edema in eyes lids, few erythematous edematous papules on cheeks, bilateral upper extremities (Figures 1 and 2), lower extremities, chest, abdomen and back. The rest of physical exam was normal. Blood work normal, urine toxicology was positive for Marijuana. EKG showed prolonged QT interval (<xref ref-type="fig" rid="fig3">Figure 3</xref>). Steroids and anti-histamine started which improved her symptoms.</p><p>Dermatology assessment: Urticarial with angioedema, may be related to lamotrigine overdose.</p></sec><sec id="s3"><title>3. DISCUSSION</title><p>In our case, the patient developed mild angioedema and urticaria, 12 - 24 hours, after she took approximately 500 mg of lamotrigine. Lamotrigine is a new antiepileptic medication approved by the US Food and Drug Administration as adjunctive treatment of partial seizures in adults and children, as well as for adjunctive therapy for primary generalized tonic-clonic seizures and Lennox-Gastaut syndrome [1,2]. It is also used as first line medication for bipolar disorder maintenance treatment [<xref ref-type="bibr" rid="scirp.32420-ref3">3</xref>]. Common side effects of lamotrigine at regular dose include nausea, vomiting, chest pain, peripheral edema, insomnia, somnolence, impaired coordination, dizziness, ataxia, irritability, rash, dermatitis, dysmenorrhea, increased libido, dyspepsia, nystagmus, abnormal vision, and in rare cases have been reported to cause multiorgan hypersensitivity reactions, life-threatening skin rashes, CNS depression, aseptic meningitis [4-7]. Overdose of lamotrigine usually causes drowsiness, lethargy, nausea, vomiting, ataxia, dizziness, tachycardia, coma, respiratory depression. There is report of a case in which lamotrigine caused anticonvulsant hypersensitivity syndrome [8,9]. The incidence of urticaria, periorbital and lip edema, immediately after Lamotrigine overdose in our patient, made us suspect overdose as the cause of the symptoms.</p></sec><sec id="s4"><title>4. CONCLUSION</title><p>Lamotrigine overdose may manifest as angioedema, and</p><p>urticaria. Health care providers should be aware about these complications and able to medically optimize the patient as needed.</p></sec><sec id="s5"><title>REFERENCES</title></sec><sec id="s6"><title>NOTES</title></sec></body><back><ref-list><title>References</title><ref id="scirp.32420-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">French, J.A., Kanner, A.M., Bautista, J., et al. (2004) Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new onset epilepsy: Report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology, 62, 1252. doi:10.1212/01.WNL.0000123693.82339.FC</mixed-citation></ref><ref id="scirp.32420-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Biton, V., Di Memmo, J., Shukla, R., et al. (2010) Adjunctive lamotrigine XR for primary generalized tonicclonic seizures in a randomized, placebo-controlled study. Epilepsy &amp; Behavior, 19, 352.  
doi:10.1016/j.yebeh.2010.07.022</mixed-citation></ref><ref id="scirp.32420-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Bowden, C.L., Asnis, G.M., Ginsberg, L.D., et al. (2004) Safety and tolerability of lamotrigine for bipolar disorder. Drug Safety, 27, 173.  
doi:10.2165/00002018-200427030-00002</mixed-citation></ref><ref id="scirp.32420-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Dichter, M.A. and Brodie, M.J. (1996) New antiepileptic drugs. The New England Journal of Medicine, 334, 1583-1590. doi:10.1056/NEJM199606133342407</mixed-citation></ref><ref id="scirp.32420-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Schaub, J.E., Williamson, P.J., Barnes, E.W. and Trewby, P.N. (1994) Multisystem adverse reaction to lamotrigine (letter). Lancet, 344, 481.  
doi:10.1016/S0140-6736(94)91818-X</mixed-citation></ref><ref id="scirp.32420-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Yuen, A.W. and Bihari, D.J. (1992) Multiorgan failure and disseminated intravascular coagulation in severe convulsive seizures (letter). Lancet, 340, 618.  
doi:10.1016/0140-6736(92)92159-D</mixed-citation></ref><ref id="scirp.32420-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Schirop, T.H., Lufft, H., Winkler, M., et al. (1994) Bronchial mucosa reaction in Lyell-Stevens-Johnson syndrome following lamotrigine. Intensivmedizin und Notfallmedizin, 31, 343.</mixed-citation></ref><ref id="scirp.32420-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Harchelroad, F., Lang, D. and Valeriano, J. (1994) Lamotrigine overdose. Veterinary &amp; Human Toxicology, 36, 372.</mixed-citation></ref><ref id="scirp.32420-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Lofton, A.L. and Klein-Schwartz, W. (2004) Evaluation of lamotrigine toxicity reported to poison control centers. The Annals of Pharmacotherapy, 38, 1811-1815.  
doi:10.1345/aph.1E192</mixed-citation></ref></ref-list></back></article>